Digital health management for preventing ischemic stroke recurrence

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent System

This study is testing a new WeChat-based system to help people who have had an ischemic stroke or transient ischemic attack manage their health and prevent future strokes.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 4490 (estimated)
• Ages: 18 Years and up
• Sex: All
• Sponsor: Beijing Tiantan Hospital (other)
• Locations: 3 sites (Beijing, Beijing Municipality and 2 other locations)
• Trial ID: NCT06783049 on ClinicalTrials.gov

What this trial studies

This study aims to develop and evaluate a WeChat-based intelligent management system designed for the secondary prevention of ischemic stroke and transient ischemic attack. Participants will be randomly assigned to receive either standard care or the digital management system, which integrates patient data with mobile IoT devices for self-monitoring. The system provides personalized feedback on risk factor control and facilitates communication between patients and healthcare providers. Follow-up assessments will occur at one year to evaluate clinical outcomes and medication adherence.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older who have experienced an acute ischemic stroke or TIA and have at least one modifiable risk factor.

Not a fit: Patients who are already enrolled in other stroke-related healthcare projects or those unable to use a smartphone may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve the management and prevention of recurrent strokes in patients.

How similar studies have performed: Other studies utilizing digital health interventions for stroke management have shown promising results, indicating potential for success in this approach.

Eligibility criteria

Inclusion Criteria:

1. Age ≥ 18 years.
2. Patients diagnosed with acute ischemic stroke or transient ischemic attack.
3. Time from onset to enrollment ≤ 14 days.
4. Presence of at least one modifiable risk factor (hypertension, diabetes).
5. Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
6. Signed informed consent by the patient or their family members.

Exclusion Criteria:

1. Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
2. Patients or family members who refuse to sign the informed consent form.
3. Pregnant or breastfeeding women.

Where this trial is running

Beijing, Beijing Municipality and 2 other locations

• Beijing Tsinghua Changgung Hospital — Beijing, Beijing Municipality, China (ACTIVE_NOT_RECRUITING)
• The First Affiliated Hospital of Shihezi University — Shihezi, Xinjiang, China (ACTIVE_NOT_RECRUITING)
• Beijing Tiantan Hospital — Beijing, China (RECRUITING)

Study contacts

• Study coordinator: Zhiyuan Feng, MD

Conditions: Ischemic Stroke, Transient Ischemic Attack, ischemic stroke, secondary prevention, digital health